CancerTrade

clinical trials reshape how medicine reaches patients. the data exists. the market to trade it doesn't. yet. cancertrade.xyz

if you had to put money on one oncology readout in the next 90 days what's your bet and why?

3 markets live on CancerTrade at launch. 🔬 MK-5684 — Merck blocking steroid hormones to treat breast, ovarian + endometrial cancer simultaneously currently recruiting | 250 patients | United States the question: does it finish on time? 🔬 Talazoparib — BRCA-altered cancers PARP inhibitor targeting recurrent + metastatic tumors with BRCA mutations active | foundation-backed | United States the question: does the biomarker signal hold? 🔬 MK-4716 — Merck solid tumors, second Merck bet on the platform recruiting | 250 patients | United States the question: 95% completion probability. is the market right? which one are you fading?

@peptidepirate early and still misunderstood

Peptides are cheat codes for the human body🏴‍☠️ Healing. Focus. Anxiety. Sleep. Body composition. Longevity. Inflammation🏴‍☠️ Simply put they are little messengers that carry a signal to help our body function better 🏴‍☠️ We are early but also late 🏴‍☠️

@m_goes_distance what if i told u that u can trade the odds? 👀

@cancertrade fixed odds

I don't think people understand what's about to happen next GLP-1s just hit 12.4% of US adults doubled in 18 months literally the fastest mainstream drug adoption of our lifetime and remember what GLP-1s were five years ago? a diabetes drug nobody outside endocrinology cared about >then Rogan talked about it >then your neighbor was on it >then Eli Lilly posted $19.8 billion in a single quarter peptides are on the exact same curve right now but faster the adoption always happens before the acceptance we have seen this movie before bio/acc

@cryptoleon wrong virus profile for covid 2.0

Hantavirus is now apparently also spreading on the mainland. 40% mortality rate. This could become worse then Corona.

@Bancrypto__ high mortality, low transmission very different setup vs covid

Will Hantavirus pandemic be bullish or bearish for crypto?

@rand_longevity and yet the entire clinical trial industry is built around cholesterol-style endpoints

your resting heart rate predicts your death way better than your cholesterol

FDA expanded access to a pancreatic cancer drug while it’s still under review. sometimes the market starts forming before approval even arrives. prediction markets make that visible.

@kayisagijr what’s the first trial you’d take a side on?

@cancertrade you guys gonna change the game

46 novel drugs got FDA approval last year. before the approval, there was a trial. before the trial readout, there was a yes/no question. CT trades elections, rates, sports, memes. cancer trials are still missing their market. until now.

imagine if you could trade the outcome of a cancer research trial must be nice

@0xBossman they carry the cycle every time

The biggest bag workers often have the smallest bags This space would die without these legends

@smileycapital more probability

the next big adopter of crypto are autonomous AI agents — 'the robot economy'

@rand_longevity if aging ends, trials become everything

most people have no idea that we are witnessing the end of aging

@peptidemaxxer trial volatility about to spike

chinese peptide suppliers are angry that the US is fabricating fentanyl stories, reshipping orders and disrupting supply chains government officials will soon intervene and negotiate serious trade agreements expect higher prices and DeSci to blow off

@jefftangx peptides

Peptides

@UAEsoltrading robotics might be the bridge between messy science and tradable signals

DeSci x Robotics is next up 👀

@UAEsoltrading just remember that desci is not only “peptide”

The peptide meta on #DeSci is dead already… Look at that chart. $46K mcap. $2K mcap. -87% in 24h. These are not research projects. They are the same "AI swarm analyzes peptide sequences" narrative copy-pasted 15 times with a different ticker. It is the AI agent meta all over again. Hundreds of projects, same pitch, same nothing underneath. But here is what nobody is talking about. DeSci as infrastructure is still almost completely unexplored. SportFi x DeSci. Imagine athlete biometric data owned by the athlete, funded by fans through tokenized research grants, with performance studies running on community compute. No sports agency taking 20%. No pharma company owning the IP. Climate science. Open datasets funded by token holders, researchers paid in real time as milestones are verified on-chain, results permanently stored and publicly accessible. No grant committee gatekeeping what gets studied. Longevity and aging research. The most underfunded category in all of science relative to its potential impact. A decentralized funding layer could route capital directly to labs that institutional money ignores. Mental health and psychedelic research. Still stigmatized by traditional funding bodies. DeSci removes the gatekeeper entirely. Materials science, energy, food systems. All of it sitting there with no decentralized funding infrastructure. The projects that survive will not be the ones that rode a peptide narrative for two weeks. They will be the ones that built the rails for how science actually gets funded, verified, and rewarded. The meta is dead. The space is not even close to being explored. #DeSci has potential don’t let it die out because of “peptides”